The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

December 31, 2011

Conditions

Allergic Asthma

Interventions

DRUG

AZD8848

Nasal spray, solution 0.6mg/ mL. Once weekly for 7 weeks, 8 doses in total.

DRUG

Placebo

Nasal spray, solution. Once weekly for 7 weeks, 8 doses in total.

Trial Locations (2)

Research Site, London

Research Site, Manchester